LP
OREX

LMR Partners’s Orexigen Therapeutics, Inc. OREX Stock Holding History

LMR Partners’s Portfolio OREX Stock Details OREX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-12,784
Closed -$55K – 609
2016
Q2 		$55K Buy
+12,784
New +$57.8K 0.01% 437

Other funds holding OREX

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

LMR Partners's OREX Position: Q3 2016 in Review

LMR Partners sold out of Orexigen Therapeutics, Inc. (OREX) in Q3 2016, closing a stake of 12,784 shares — an estimated $55K sold.

LMR Partners first reported a position in OREX in Q2 2016 and held it in 1 quarter. The position peaked at $55K in Q2 2016. 55 funds tracked by Wall St. Rank hold OREX as of Q3 2016.

  • LMR Partners reported no remaining Orexigen Therapeutics, Inc. position as of Q3 2016 after selling out during the quarter.
  • LMR Partners sold 12,784 Orexigen Therapeutics, Inc. shares in Q3 2016, an estimated $55K.
  • LMR Partners first reported a position in Orexigen Therapeutics, Inc. in Q2 2016 and held it in 1 quarter.
  • LMR Partners's Orexigen Therapeutics, Inc. position peaked at $55K in Q2 2016.
  • 55 funds tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q3 2016.

Based on LMR Partners's 13F filing for Q3 2016, filed 1 Nov 2016.